Immuron (Warrant)

YTD

ALL

Why Robinhood?

You can watch IMRNW and buy or sell other stocks, ETFs, and their options commission-free!

About IMRNW

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments.

CEO

Steven Lydeamore, MBA

CEOSteven Lydeamore, MBA

Employees

—

Employees—

Headquarters

Blackburn, Victoria (VIC)

HeadquartersBlackburn, Victoria (VIC)

Founded

1994

Founded1994

Employees

—

Employees—

IMRNW Key Statistics

Market cap

—

Market cap—

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

—

Average volume—

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

—

52 Week high—

52 Week low

—

52 Week low—

IMRNW News

TipRanks 2d

Immuron CEO to Present at AusBiotech Invest 2025 Conference

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 5d

Immuron Announces New Securities Issue to Boost R&D